When accurate diagnoses and treatments are delayed, patients pay the price—clinically, financially, and emotionally. While it’s not a panacea for all the challenges patients face, this white paper explores how life science marketers can be part of the solution through smarter HCP and DTC marketing strategies.
White Paper: The Marketer's Role in Earlier Disease Intervention
Ideas, Insights, and Inspiration for Modern Healthcare Marketers
Explore our full library of resources developed by healthcare industry leaders aimed to spark actionable ideas.
Let's Talk
Want patients and providers talking about your brand? Talk to us first.
Stay Informed and Connected.
Search Resources
All topics
48550987443
All dates
White Paper: The Marketer's Role in Earlier Disease Intervention
When accurate diagnoses and treatments are delayed, patients pay the price—clinically, financially, and emotionally. While it’s not a panacea for all the challenges patients face, this white paper explores how life science marketers can be part of the solution through smarter HCP and DTC marketing strategies.
All About the EHR: A Q&A on Digital EHR Marketing for HCP Engagement
Digital EHR marketing has become one of the most effective ways for life science brands to reach healthcare providers (HCPs) at meaningful moments in the care journey. As more vendors enter the market with varying claims, many marketers are trying to understand what “EHR advertising” really means and how it fits within omnichannel HCP engagement.
To bring clarity to this topic, we spoke with Louis Trivento, SVP of Strategic Partnerships at OptimizeRx, about how EHR placements work, how physicians perceive them, and how brands can use targeting and measurement to drive performance.
Omnichannel Marketing in Pharma Finally Works: The Precision Change
For years, “omnichannel” has been one of the most overused words in pharmaceutical marketing. Yet for many brands, it has delivered underwhelming results. Campaigns were launched with good intentions—reach patients everywhere, reinforce messages with HCPs, influence decisions across the journey—but the execution often relied on disconnected tactics, incomplete data, and static audiences that didn’t reflect real patient needs.